BB Biotech AG (BBZA.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.48B |
| Enterprise Value | 2.38B |
| P/E Ratio | -8.85 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | -95.03 |
| Price/Book Ratio | 0.95 |
| Enterprise/Revenue | -81.62 |
| Enterprise/EBITDA | 36.13 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 10.64 |
| Operating Margin | 1.72 |
AD
Management Effectiveness
| Return On Assets | -0.11 |
| Return On Equity | -0.12 |
Income Statement
| Revenue | 111.63M |
| Revenue/Share | -0.48 |
| Gross Profit | 111.63M |
| EBITDA | 80.33M |
| Net Income | 75.9M |
| Diluted EPS | 1.38 |
Balance Sheet
| Total Cash | 356.18M |
| Total Cash/Share | 6.5 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 48.07 |
Price History
| 52-Week Change | 55.36 |
| 52-Week High | 49.7 |
| 52-Week Low | 31.55 |
| Moving Average 50 Days | 33.4 |
| Moving Average 200 Days | 33.4 |
Statistics
| Average Volume | 10,645.98 |
| Shares Outstanding | 55.15M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.25 |
| Trailing Annual Dividend Yield | 4.93 |
| Payout Ratio | -0.35 |
| Last Split Factor | 5:1 |
| Last Split Date | March 29, 2016 |
AD
